Mivacron (Mivacurium Chloride)

Mivacurium Chloride, the active ingredient in Mivacron, is a non-depolarizing neuromuscular blocker presented as an injection solution for intravenous use. It provides rapid skeletal muscle relaxation to facilitate endotracheal intubation, surgical muscle relaxation, and mechanical ventilation in patients undergoing anesthesia. GNH USA supplies Mivacron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mivacron is a short‑acting non‑depolarizing neuromuscular blocker used in the peri‑operative setting to achieve controlled skeletal muscle relaxation.

- Adjunct to anesthesia (endotracheal intubation): Enables rapid and safe airway management by producing brief muscle paralysis. - Muscle relaxation during surgery: Provides a predictable depth of relaxation for optimal surgical conditions. - Facilitation of mechanical ventilation: Allows controlled ventilation in patients requiring assisted breathing.

Mivacron may cause a range of adverse reactions, most of which are dose‑related and transient.

Common Side Effects: - Flushing: transient redness of the skin. - Mild hypotension: slight drop in blood pressure. - Tachycardia: increased heart rate. - Nausea: feeling of queasiness. - Headache: mild cranial discomfort. - Injection site pain: soreness at the puncture site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate intervention. - Prolonged apnea: extended respiratory paralysis. - Severe hypotension: marked drop in blood pressure. - Bronchospasm: constriction of airway smooth muscle. - Cardiac arrhythmia: irregular heart rhythm. - Hyperkalemia: elevated serum potassium levels.

When using Mivacron, clinicians should observe specific safety measures to minimize risk.

- Patient assessment: Evaluate neuromuscular function and baseline respiratory status before administration. - Dosage adjustment: Use caution in hepatic or renal impairment as clearance may be reduced. - Monitoring: Maintain continuous neuromuscular and cardiovascular monitoring throughout the procedure. - Contraindications: Avoid in patients with known hypersensitivity to mivacurium or related compounds. - Drug interactions: Be aware of agents that may prolong blockade, such as cholinesterase inhibitors. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mivacron can interact with several drug classes, affecting the depth and duration of neuromuscular blockade.

Major Interactions (Avoid): - Cholinesterase inhibitors (e.g., neostigmine): may prolong paralysis. - Other neuromuscular blockers: additive blockade risk. - Aminoglycoside antibiotics: potentiate muscle relaxation.

Moderate Interactions (Monitor Closely): - Inhalational anesthetics (e.g., sevoflurane): may enhance block. - Magnesium sulfate: can increase sensitivity. - Calcium channel blockers: may modify neuromuscular response.